Add to ORKG[[sponsorship]]統計科學研究所[[note]]出版中(submitted);[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Drexel&SrcApp=hagerty_opac&KeyRecord=2045-2322&DestApp=JCR&RQ=IF_CAT_BOXPLO
Lung cancer remains the leading cause of cancer-related deaths worldwide. The recurrence rate ranges...
[[sponsorship]]統計科學研究所[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/Ga...
Objective To construct a diagnostic signature to distinguish lung adenocarcinoma from lung squamous ...
[[sponsorship]]統計科學研究所[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/Ga...
<div><p>Although several prognostic signatures have been developed in lung cancer, their application...
[[sponsorship]]生物醫學科學研究所[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/...
Although several prognostic signatures have been developed in lung cancer, their application in clin...
[[sponsorship]]統計科學研究所[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/Ga...
Although several prognostic signatures have been developed in lung cancer, their application in clin...
Although several prognostic signatures have been developed in lung cancer, their application in clin...
Shicheng Li,1,* Yunpeng Xuan,1,* Bing Gao,2 Xiao Sun,1 Shuncheng Miao,1 Tong Lu,1 Yuanyong Wang,1 We...
Current research has identified several potential biomarkers for lung cancer diagnosis or prognosis....
Purpose: Improving outcomes for early-stage lung cancer is a major research focus at present because...
Background: Stage I lung adenocarcinoma is usually not treated with adjuvant chemotherapy; however, ...
Background. Prognosis is a main factor affecting the survival of patients with lung adenocarcinoma (...
Lung cancer remains the leading cause of cancer-related deaths worldwide. The recurrence rate ranges...
[[sponsorship]]統計科學研究所[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/Ga...
Objective To construct a diagnostic signature to distinguish lung adenocarcinoma from lung squamous ...
[[sponsorship]]統計科學研究所[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/Ga...
<div><p>Although several prognostic signatures have been developed in lung cancer, their application...
[[sponsorship]]生物醫學科學研究所[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/...
Although several prognostic signatures have been developed in lung cancer, their application in clin...
[[sponsorship]]統計科學研究所[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/Ga...
Although several prognostic signatures have been developed in lung cancer, their application in clin...
Although several prognostic signatures have been developed in lung cancer, their application in clin...
Shicheng Li,1,* Yunpeng Xuan,1,* Bing Gao,2 Xiao Sun,1 Shuncheng Miao,1 Tong Lu,1 Yuanyong Wang,1 We...
Current research has identified several potential biomarkers for lung cancer diagnosis or prognosis....
Purpose: Improving outcomes for early-stage lung cancer is a major research focus at present because...
Background: Stage I lung adenocarcinoma is usually not treated with adjuvant chemotherapy; however, ...
Background. Prognosis is a main factor affecting the survival of patients with lung adenocarcinoma (...
Lung cancer remains the leading cause of cancer-related deaths worldwide. The recurrence rate ranges...
[[sponsorship]]統計科學研究所[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/Ga...
Objective To construct a diagnostic signature to distinguish lung adenocarcinoma from lung squamous ...